« Return to Tobacco Cessation Page

Tobacco Cessation News and Updates

  • Morbidity and Mortality Weekly Report (MMWR)

    E-cigarette Unit Sales, by Product and Flavor Types—United States, 2014 – 2020

    Early Release / September 9, 2020 / Vol. 69

    Pre-filled cartridges remain the leading type of e-cigarettes sold, but disposable product sales increased within the past year. Moreover, among pre-filled cartridge sales, menthol flavored products comprised more than three-fifths (61.8%) of all flavored products sold. Read more.

  • Morbidity and Mortality Weekly Report (MMWR)

    E-cigarette Use Among Middle and High School Students — United States, 2020

    Early Release / September 9, 2020 / Vol. 69

    About 3.6 million U.S. youth reported current (in the past 30 days) e-cigarette use in 2020, reflecting a decline from 5.4 million in 2019, according to the National Youth Tobacco Survey (NYTS) conducted in partnership with the U.S. Food and Drug Administration (FDA). Read more.

  • Morbidity and Mortality Weekly Report (MMWR)

    Tobacco Product Use Among High School Students—Youth Risk Behavior Survey, United States, 2019

  • Pathological Findings in Suspected Cases of E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI): A Case Series

    The Lancet Respiratory Medicine

    In August 2019, the Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), and state, territorial, local, and Tribal health departments began the investigation of a national outbreak of e-cigarette, or vaping, product-use associated lung injury (EVALI). After peaking in September 2020, EVALI cases and deaths have since declined. This study describes the pathological findings in autopsy and biopsy tissues submitted to CDC for the evaluation of suspected EVALI. This study also includes the first description of findings in a series of autopsies evaluated for suspected EVALI. The article and related audio are available online.

  • COVID-19 Pandemic and Tobacco Sales in the United States
    The Network for Public Health Law provides insights on the COVID-19 pandemic's impact on tobacco sales. "COVID-19 has unquestionably altered every facet of daily life, including where and how one purchases goods. For those who use tobacco products, including vape products, a patchwork of state laws continues to determine where these products may be sold because of orders classifying businesses as essential and non-essential." Read more here.
  • Demographics, Substance Use Behaviors, and Clinical Characteristics of Adolescents With e-Cigarette, or Vaping, Product Use–Associated Lung Injury (EVALI) in the United States in 2019
    The Centers for Disease Control and Prevention (CDC) has released the following article in the journal, JAMA Pediatrics. Compared with adults, it appears that adolescents with EVALI more frequently have a history of asthma and mental, emotional, or behavioral disorders, such as ADHD, and report nonspecific problems, including gastrointestinal and constitutional symptoms; therefore, obtaining a confidential substance use history that includes e-cigarette or vaping product use is recommended. Read more here.
  • Budgetary Impact from Multiple Perspectives of Sustained Antitobacco National Media Campaigns to Reduce the Harms of Cigarette Smoking
    This report estimated the budgetary impact and time to breakeven from societal, all-payer, Medicare, Medicaid and private insurer perspectives of national antitobacco media campaigns in the USA. Read more here.
  • Flavors Are a Major Driver of the Youth E-Cigarette Epidemic
    CDC’s Office on Smoking and Health has released the following tobacco-related comment in the American Journal of Public Health (AJPH). Read more here.
  • Youth E-Cigarette Use and the Food and Drug Administration’s Multifaceted Approach
    Results from the National Youth Tobacco Survey (NYTS)—an annual survey conducted by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention—showed that in 2019, more than five million US middle and high school students reported current use (at least once in the past 30 days) of e-cigarettes and other electronic nicotine delivery systems (ENDS), and nearly one million students cited daily use. Read more here.
  • The Risks of Vaping
    Vaping devices, also known as e-cigarettes, vape pens, and e-hookahs among other terms, come in many shapes and sizes. These devices can expose the lungs to a variety of chemicals, such as (nicotine) or marijuana (THC), flavorings, and other ingredients that are added to vaping liquids. Read more here.
  • Morbidity and Mortality Weekly Report (MMWR)
    State and Territorial Laws Prohibiting Sales of Tobacco Products to Persons Aged under 21 Years — United States, December 20, 2019
    February 20, 2020 / Vol. 69 / 07 Read more here.
  • Morbidity and Mortality Weekly Report (MMWR)
    State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments—United States, 2008–2018
    February 13, 2020 / Vol. 69 / 06 Read more here.
  • US Adults’ Perceptions About the Harms of Nicotine in Electronic Vapor Products on the Adolescent Brain, United States, 2016–2017
    Disease Control and Prevention (CDC) researchers assessed adults’ perceptions about the harms of nicotine in EVP to the adolescent brain by using data from cross-sectional internet surveys conducted in 2016 and 2017. Read more here.
  • National Trends and State-Level Variation in the Duration of Incoming Quitline Calls to 1-800-QUIT-NOW During 2012–2015
    Using data on the duration of incoming quitline calls to 1-800-QUIT-NOW from 2012 through 2015, authors examined national trends and state-level variation in average call duration Read more here.
  • Feasibility of Administering an Electronic Version of the National Youth Tobacco Survey in a Classroom Setting
    A pilot study was conducted to determine the feasibility and potential benefits of administering an electronic mode of the NYTS in school settings. Read more here.
  • E-Cigarette Advertising Expenditures in the United States, 2014-2018
    Tobacco product advertising has been shown to reach, and influence initiation among youth. This study assessed trends in e-cigarette advertising expenditures in the U.S during 2014-2018. Read more here.
  • Morbidity and Mortality Weekly Report
    State and Territorial Laws Prohibiting Sales of Tobacco Products to Persons Aged under 21 Years — United States, December 20, 2019. Read more here.
  • January 21, 2020
    Combined Prenatal Smoking and Drinking Greatly Increases SIDS Risk
    The NIH-funded Safe Passage Study provides a look at how SIDS, the sudden, unexplained, death of an infant under 1 year of age is influenced by the timing and amount of prenatal exposure to tobacco and alcohol. Children born to mothers who both drank and smoked beyond the first trimester of pregnancy have a 12-fold increased risk for Sudden Infant Death Syndrome (SIDS) compared to those unexposed or only exposed in the first trimester of pregnancy. Read more here.
  • February 26, 2020
    Adults' attitudes toward raising the minimum age of sale for tobacco products to 21 years, United States, 2014–2017
    A study published in Preventive Medicine examines the changes in attitudes toward Tobacco 21 polices during 2014-2017. Read more here.
  • December 6, 2019
    6.2 Million Middle and High School Students Used Tobacco Products in 2019
    E-cigarettes most commonly used tobacco product
    Tobacco use is the leading cause of preventable disease, disability, and death in the United States. Most tobacco product use begins during adolescence. In recent years, tobacco products have evolved to include various smoked, smokeless, and electronic products. According to data released in the December 5, 2019 Morbidity and Mortality Weekly Report about 6.2 million U.S. middle and high school students were current (past 30-day) users of some type of tobacco product in 2019, according to new National Youth Tobacco Survey (NYTS). Read more here.
  • December 4, 2019
    Webinar Slides: An Update on CDC’s Response to E-cigarette, or Vaping, product use Associated Lung Injury (EVALI)
    The latest national and state findings suggest products containing THC, particularly those from informal sources (e.g. friends, family members, illicit dealers), are linked to most of the cases and play a major role in the outbreak. Slides from the webinar are available here.
  • October 25, 2019
    E-cigarette Updates for the Week ending October 25, 2019
  • September 12, 2019
    The Iipay Nation of Santa Ysabel announced that it was temporarily suspending the sales of all cannabis-containing vaping products at a dispensary on Tribal lands in light of the recent outbreak of vaping-related lung injuries and deaths.  Read more here.
  •  September 24, 2019
    The Oglala Sioux Tribal Council passed an ordinance to ban all electronic smoking devices on the Pine Ridge Reservation. The ban took effect immediately but prosecution for violations was delayed for 30 days after enactment. Unlike the temporary state action taken recently in response to the outbreak of vaping-related lung injuries and increase in youth e-cigarette use, the ban enacted by the Oglala Sioux Tribe is permanent. Read more here.
  • October 7, 2019
    The Lac Courte Oreilles Tribal Governing Board voted unanimously to ban vaping product sales in all tribal retail outlets and use of vaping products on all Tribal property.  Unlike temporary state action, this ban is permanent. Read more here.
  • October 11, 2019
    The Puyallup Tribal Council instituted a ban on the sale of flavored vaping products, including both tobacco and marijuana, that will last for 100 days.  The ban went into effect for flavored marijuana vaping products on October 11, 2019 and for flavored tobacco vaping products on November 1, 2019.
  • October 24, 2019
    It was reported that Turtle Mountain Band of Chippewa Tribe also decided to ban the sale of all vaping products on Tribal land; use of vaping products will remain lawful on the reservation.  The ban went into effect at the end of October 2019 and places a permanent restriction on vaping product sales. Read more here
  • November 5, 2019
    The Muckleshoot Tribal Council banned the sale of flavored vaping products.  Additionally, it decided to restrict sales of tobacco products, including vaping products, to those who are 21 or older.  Unlike recent temporary state action to address the vaping health crisis, this vaping product ban is permanent.
  • November 5, 2019
    e-Cigarette Use Among Youth in the United States, 2019. Full article available here.
  • November 1, 2019
    MMWR: Tobacco Use in Top-Grossing Movies — United States, 2010–2018Available here
  • November 1, 2019
    MMWR: Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, October 2019Available here
  • November 19, 2019
    MMWR: Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019Available here
  • CDC Update: Outbreak of Lung Injury Associated with the Use of E-Cigarette or Vaping ProductsAvailable here.
  • November 22, 2019
    MMWR: Characteristics of Hospitalized and Non-hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019Available here
  • FDA Reopens Comment Period for New Cigarette Health Warnings; Additional Materials Available - Deadline: Wednesday, November 27, 2019
    • The Food and Drug Administration (FDA has reopened the comment period for the “Required Warnings for Cigarette Packages and Advertisements” proposed rule published on Aug. 16, 2019, which when finalized, would require new cigarette health warnings on cigarette packages and in advertisements to promote greater public understanding of the negative health consequences of smoking. FDA has placed additional materials in the docket and reopened the public comment period for 15 days to allow comment on the additional materials. Read more here.

Public Health Inquiries:

Tyler Dougherty, MPH
Director of Public Health Policy and Programs

National Indian Health Board
910 Pennsylvania Ave, SE
Phone: 202-922-0100
Washington, DC 20003
[email protected]